[go: up one dir, main page]

WO2008035376A3 - A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof - Google Patents

A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof Download PDF

Info

Publication number
WO2008035376A3
WO2008035376A3 PCT/IN2007/000374 IN2007000374W WO2008035376A3 WO 2008035376 A3 WO2008035376 A3 WO 2008035376A3 IN 2007000374 W IN2007000374 W IN 2007000374W WO 2008035376 A3 WO2008035376 A3 WO 2008035376A3
Authority
WO
WIPO (PCT)
Prior art keywords
insert
preparation
erodible
conditions
bio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2007/000374
Other languages
French (fr)
Other versions
WO2008035376A4 (en
WO2008035376A2 (en
Inventor
Janumala Hadassah
Praveen Kumar Sehgal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Council of Scientific and Industrial Research CSIR
Original Assignee
Council of Scientific and Industrial Research CSIR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Council of Scientific and Industrial Research CSIR filed Critical Council of Scientific and Industrial Research CSIR
Publication of WO2008035376A2 publication Critical patent/WO2008035376A2/en
Publication of WO2008035376A3 publication Critical patent/WO2008035376A3/en
Publication of WO2008035376A4 publication Critical patent/WO2008035376A4/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention provides a novel bio-erodible ophthalmic insert a process for the preparation of the said bio-erodible insert. In the said process collagen is treated with organic polar solvents, hydrophilic polymers and therapeutically active substances under controlled conditions. The resulting solution is air dried in a dust free chamber to make collagen film. This film is cut into shape to obtain insert, which is subjected to cross-linking with UV irradiation followed by conventional sterilization. The prepared inserts are very effective for temporary punctal occlusion in various corneal conditions and are very effective to treat dry eye syndrome due to occupational conditions.
PCT/IN2007/000374 2006-09-19 2007-08-30 A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof Ceased WO2008035376A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2064DE2006 2006-09-19
IN2064/DEL/2006 2006-09-19

Publications (3)

Publication Number Publication Date
WO2008035376A2 WO2008035376A2 (en) 2008-03-27
WO2008035376A3 true WO2008035376A3 (en) 2008-11-20
WO2008035376A4 WO2008035376A4 (en) 2009-01-29

Family

ID=39092185

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000374 Ceased WO2008035376A2 (en) 2006-09-19 2007-08-30 A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof

Country Status (1)

Country Link
WO (1) WO2008035376A2 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3184526T3 (en) 2005-12-13 2019-01-14 Incyte Holdings Corp PYRROLO [2,3-D] PYRIMIDINE DERIVATIVES AS A JANUS-KINASE INHIBITOR
EP2740731B1 (en) 2007-06-13 2016-03-23 Incyte Holdings Corporation Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
CN101683538B (en) * 2008-09-28 2013-01-02 上海市第十人民医院 Lacrimal passage stopper and preparation method thereof
CA2750242C (en) 2009-02-12 2018-05-22 Incept, Llc Drug delivery through hydrogel plugs
WO2010135621A1 (en) 2009-05-22 2010-11-25 Incyte Corporation 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
ES2487542T3 (en) 2009-05-22 2014-08-21 Incyte Corporation N- (hetero) aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo [2,3-d] pyrimidines and pyrrol-3-yl-pyrrolo [2,3-d] pyrimidines as Janus kinase inhibitors
WO2011028685A1 (en) 2009-09-01 2011-03-10 Incyte Corporation Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
SMT201800137T1 (en) 2010-03-10 2018-07-17 Incyte Holdings Corp Piperidin-4-yl azetidine derivatives as jak1 inhibitors
PH12012502296B1 (en) 2010-05-21 2017-10-06 Incyte Holdings Corp Topical formulation for a jak inhibitor
ES2536415T3 (en) 2010-11-19 2015-05-25 Incyte Corporation Pyrrolopyridines and heterocyclic substituted pyrrolopyrimidines as JAK inhibitors
SG190839A1 (en) 2010-11-19 2013-07-31 Incyte Corp Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
WO2012177606A1 (en) 2011-06-20 2012-12-27 Incyte Corporation Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as jak inhibitors
TW201313721A (en) 2011-08-18 2013-04-01 Incyte Corp Cyclohexyl azetidine derivatives as JAK inhibitors
UA111854C2 (en) 2011-09-07 2016-06-24 Інсайт Холдінгс Корпорейшн METHODS AND INTERMEDIATE COMPOUNDS FOR JAK INHIBITORS
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
WO2013173720A1 (en) 2012-05-18 2013-11-21 Incyte Corporation Piperidinylcyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
PE20151157A1 (en) 2012-11-15 2015-08-19 Incyte Corp SUSTAINED RELEASE RUXOLITINIB DOSAGE FORMS
LT3489239T (en) 2013-03-06 2022-03-10 Incyte Holdings Corporation JAK INHIBITOR MANUFACTURING METHODS AND INTERMEDIATES
UA120499C2 (en) 2013-08-07 2019-12-26 Інсайт Корпорейшн TREATMENT OF DISEASES WITH THE USE OF DELAYED DOSAGE FORMS FOR JAK1 INHIBITOR
WO2015184305A1 (en) 2014-05-30 2015-12-03 Incyte Corporation TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
WO2019113487A1 (en) 2017-12-08 2019-06-13 Incyte Corporation Low dose combination therapy for treatment of myeloproliferative neoplasms
IL276302B2 (en) 2018-01-30 2023-11-01 Incyte Corp Processes for preparing [1-(3-fluoro-2-tripluoromethyl(isonicotinyl)piperidine-one]
SMT202400306T1 (en) 2018-03-30 2024-09-16 Incyte Corp Treatment of hidradenitis suppurativa using jak inhibitors
US11833155B2 (en) 2020-06-03 2023-12-05 Incyte Corporation Combination therapy for treatment of myeloproliferative neoplasms

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164559A (en) * 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
US5185152A (en) * 1990-01-10 1993-02-09 Peyman Gholam A Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
WO2000059420A1 (en) * 1999-04-01 2000-10-12 The Uab Research Foundation Improved conjunctival inserts for topical delivery of medication or lubrication
WO2006031658A2 (en) * 2004-09-10 2006-03-23 Allergan, Inc. Therapeutic lacrimal canalicular inserts and related methods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164559A (en) * 1977-09-21 1979-08-14 Cornell Research Foundation, Inc. Collagen drug delivery device
US5185152A (en) * 1990-01-10 1993-02-09 Peyman Gholam A Method and apparatus for controlled release drug delivery to the cornea and anterior chamber of the eye
WO2000059420A1 (en) * 1999-04-01 2000-10-12 The Uab Research Foundation Improved conjunctival inserts for topical delivery of medication or lubrication
WO2006031658A2 (en) * 2004-09-10 2006-03-23 Allergan, Inc. Therapeutic lacrimal canalicular inserts and related methods

Also Published As

Publication number Publication date
WO2008035376A4 (en) 2009-01-29
WO2008035376A2 (en) 2008-03-27

Similar Documents

Publication Publication Date Title
WO2008035376A3 (en) A novel bio-erodible insert for ophthalmic applications and a process for the preparation thereof
WO2008008953A3 (en) Method and apparatus for skin reduction
DK2712610T3 (en) Methods for the preparation of cyclic lipid implants for intraocular use
WO2008039397A3 (en) Method and intra-sclera implant for treatment of glaucoma and presbyopia
NO20072170L (en) Ophthalmic compositions and methods for treating eyes
WO2008029276A8 (en) Compositions and methods for the treatment of ophthalmic disease
TW200633709A (en) Aminopyrazine analogs for treating glaucoma and other rho kinase-mediated diseases and conditions
BR112019000178A2 (en) silicone hydrogels comprising n-alkyl methacrylamides and contact lenses made from them
WO2008011836A3 (en) Ophthalmic solutions
KR20170035984A (en) Lamellar Cornea Preservation Solution
WO2013115861A3 (en) Method and apparatus for treating an ocular disorder
JP2007536220A5 (en)
WO2008150085A3 (en) 3',4',5-trimethoxy flavone derivatives as stimulant of mucus secretion, method of the same, and pharmaceutical composition comprising the same
EP3964201A4 (en) OPHTHALMIC PHARMACEUTICAL COMPOSITION, PROCESS FOR MANUFACTURE THEREOF AND APPLICATION THEREOF
Lou et al. A moist edge environment aids the regeneration of traumatic tympanic membrane perforations
CN204192856U (en) A kind of degradable eye maintenance device
WO2016060917A3 (en) Formulations for histatin therapeutics
RU2012126633A (en) METHOD FOR SCREENING AN AGENT SUITABLE FOR TREATING A DRY EYE SYNDROME AND / OR CORNEAL AND CONJUNCTIVES, PHARMACEUTICAL COMPOSITION OBTAINED WITH THIS METHOD
EA200700772A1 (en) POLYAMINE ANALOGUES AS A THERAPEUTIC TREATMENT FOR EYE DISEASES
KR102266578B1 (en) Hyaluronic acid-based ophthalmic drug carrier
RU2010135224A (en) METHOD FOR SURGICAL TREATMENT OF MACULAR Edema AFTER CATARACT PHACOEMULSIFICATION
BRPI0811223A2 (en) Methods for modulating an inflammation in a patient, and for treating, controlling, reducing or ameliorating an eye or ophthalmic infection and an inflammatory sequela of the same, use of a fluorokinoline, and, as a pharmaceutical composition.
RU2018119126A (en) APPLICATION IN THERAPY OF STERILE WATER OPHTHALMOLOGICAL SOLUTION
BRPI0416037A (en) processes and devices for treating epithelium
EA200801173A3 (en) METHOD OF CORRECTION OF VISION AND DEVICE FOR ITS IMPLEMENTATION

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07827549

Country of ref document: EP

Kind code of ref document: A2

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07827549

Country of ref document: EP

Kind code of ref document: A2